Showing results (1141-1150 of 1,512) with videos related to
Sort By:
Pageof 152
The New England Journal of Medicine|December 4, 2014
First-line crizotinib versus chemotherapy in ALK-positive lung cancerBenjamin J Solomon, Tony Mok, Dong-Wan Kim, et al.Chinese Journal of Cancer|February 10, 2017
Proportion and clinical features of never-smokers with non-small cell lung cancerJaeyoung Cho, Sun Mi Choi, Jinwoo Lee, et al.BMJ Open|August 29, 2024
Sabatolimab in combination with spartalizumab in patients with non-small cell lung cancer or melanoma who received prior treatment with anti-PD-1/PD-L1 therapy: a phase 2 multicentre studyChia-Chi Lin, Giuseppe Curigliano, Armando Santoro, et al.The Lancet. Oncology|December 3, 2014
Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trialPasi A Jänne, Sai-Hong I Ou, Dong-Wan Kim, et al.The New England Journal of Medicine|November 18, 2020
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung CancerAlice T Shaw, Todd M Bauer, Filippo de Marinis, et al.Kidney Research and Clinical Practice|November 16, 2021
Renal outcomes of laparoscopic versus open surgery in patients with rectal cancer: a propensity score analysisJin Hyuk Paek, Sung Il Kang, Jiwon Ryu, et al.Frontiers in Aging Neuroscience|August 4, 2022
The association of serum uric acid with cognitive impairment and ATN biomarkersShan Huang, Jun Wang, Dong-Yu Fan, et al.Head & Neck|June 25, 2015
Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experienceChan-Young Ock, Bhumsuk Keam, Yoojoo Lim, et al.Pancreas|September 14, 2018
Grading by the Ki-67 Labeling Index of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy Specimens of Pancreatic Neuroendocrine Tumors Can Be UnderestimatedHee Sang Hwang, YunJae Kim, Soyeon An, et al.Cancer Research and Treatment|March 28, 2022
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup AnalysisByoung Chul Cho, Dong-Wan Kim, Ullas Batra, et al.Pageof 152